![Peter Moran](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Moran
Founder at Singular ID Pte Ltd.
Profile
Peter Moran is Chief Technology Officer and a Director Singular ID Pte Ltd.
Previously, he was a Senior Scientist of IMRE.
Dr. Morean received a PhD in Engineering and an MS degree in Applied Mathematics and Engineering from Brown University.
Peter Moran active positions
Companies | Position | Start |
---|---|---|
Singular ID Pte Ltd.
![]() Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore. | Founder | - |
Former positions of Peter Moran
Companies | Position | End |
---|---|---|
Cypress Bioscience, Inc.
![]() Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Corporate Officer/Principal | - |
Training of Peter Moran
Brown University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Singular ID Pte Ltd.
![]() Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore. | Technology Services |
Cypress Bioscience, Inc.
![]() Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Peter Moran